Zdrowie i gospodarka · 11/05/2004

FDA Publishes Guidance Document for Immunomagnetic Circulating Cancer Cell Selection and Enumeration System

The Food and Drug Administration (FDA) has released a guidance document outlining the requirements for the immunomagnetic circulating cancer cell selection and enumeration system, a Class II device that must comply with special controls, and is now in effect as the special control for this device.